# DaltonTx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/daltontx

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.daltontx.com/
- Total disclosed funding: $5.4M
- Latest round: Seed (Sep 12, 2025)
- Investors on record: 4

## About

Based in the UK, DaltonTx provides advanced artificial intelligence solutions for the pharmaceutical and biotechnology sectors, streamlining drug discovery processes.DaltonTx is focused on delivering AI-driven platforms to enhance drug discovery. The company is headquartered in London, UK. On September 23, 2025, DaltonTx raised GBP 4 million in SEED funding, with investors including IQ Capital, Oxford University Innovation Limited, Redalpine, and Seedcamp, amounting to a total of GBP 4 million raised. The CEO and founder details are currently unavailable.DaltonTx specializes in AI-enabled platforms that facilitate drug discovery, enhancing research and development efficiency in the pharmaceutical, biotechnology, and contract research organization sectors. Its offerings include an adaptive intelligent system that integrates into existing workflows for data ingestion, model training, molecule generation, and experiment prioritization, allowing scientists to utilize machine intelligence in their drug discovery efforts, primarily serving clients in North America and Europe.DaltonTx operates on a B2B revenue model, primarily through subscriptions and partnerships with pharmaceutical and biotech companies. Clients pay for access to its AI cloud platform, which assists in developing AI-enabled drug discovery capabilities for both biologics and small molecules, typically through multi-year contracts including tailored support and training services. Specific pricing plans and revenue details are not publicly disclosed.In September 2025, DaltonTx raised GBP 4 million in seed funding to enhance its artificial intelligence systems supporting drug research and development. The company plans to utilize this funding to develop new products that improve drug research processes and expand into additional markets, although specific geographic regions targeted for expansion have not been detailed.

## Funding rounds

- Seed, Sep 12, 2025, $5.4M — Seedcamp, IQ Capital, Redalpine, Oxford University Innovation Limited

## Investors

- Seedcamp (https://capitalatlas.ai/funds/seedcamp) — Seed
- IQ Capital (https://capitalatlas.ai/funds/iq-capital) — Seed
- Redalpine (https://capitalatlas.ai/funds/redalpine) — Seed
- Oxford University Innovation Limited — Seed